Belviq (generic name: lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. A U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. As a result, the FDA issued a full Belviq recall in February 2020. If you or a loved one took Belviq, Belviq XR, or another brand of lorcaserin, and you were diagnosed with cancer, you may be entitled to file a Belviq lawsuit and receive compensation from the drug’s manufacturer. Fill out a free case review form to find out if you are owed money for damages and talk to Belviq Lawyer Timothy L. Miles today. Does Belviq Cause Cancer?Weight-loss drugs are not known for their safety; unfortunately, Belviq is no exception resulting in a Belviq recall. In a five-year, double-blind study of 12,000 patients, those taking Belviq were more likely to be diagnosed with cancer than those taking a placebo (sugar pill). The FDA stated, “A range of cancer types was reported, with several different types of cancers occurring more frequently in the lorcaserin group,” including: Pancreatic cancer; Colorectal cancer; Lung cancer. Has the FDA Recalled Belviq?Yes. In February 2020, the FDA requested that the Belviq Recall and for to Eisai pull all Belviq and Belviq XR products from the market. Eisai has complied with this request. Should I Stop Taking Belviq?Anyone taking this drug should talk to a healthcare professional about the risks of taking Belviq and their options. Where Can I Report Belviq Side Effects?If you have experienced unexpected Belviq side effects, you can report them to the FDA using this form. You may also want to speak with Belviq Lawyer Timothy L. Miles about your Belviq side effects. Who Is Eligible for a Belviq Class Action Lawsuit?If you took Belviq or its generic equivalent and were diagnosed with cancer, you should consider taking legal action against the drug’s manufacturer. If you meet these criteria, you may have a case and can file a belviq class action lawsuit:
What Can I Recover from a Belviq Lawsuit?Every case is unique, but people who successfully file drug or medical device lawsuits can recover money for some of the following damages: Past and future medical bills (including medication, hospital stays, and in-home care); Pain and suffering; Lost wages; Loss of earning capacity; Funeral expenses (in the event of a loved one’s death). Broadly speaking, a plaintiff in a Belviq lawsuit could be entitled to compensation for any past and future costs associated with their cancer diagnosis. Call a Belviq Lawyer About a Belviq Class Action LawsuitIf you took Belviq and have been diagnosed with cancer, you could be owed significant compensation for medical costs, pain and suffering, lost wages, and other damages. You should contact Belviq lawyer Timothy L. Miles as soon as possible to determine the best course of action including filing a Belviq class action lawsuit or an individual Belviq Lawsuit if you experienced Belviq side effects. These cases are time-sensitive, including the Belviq class action lawsuit, so do not wait. Call today and see what a Belviq Lawyer can do for you. Timothy L. Miles, Esq.Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more. Comments are closed.
|
AuthorTimothy L. Miles Archives
December 2024
Categories
All
|
HoursSITEMAP
|
|